PS2 transfection of Murine Adenocarcinoma Cell line (410.4) enhances dispersed growth pattern in 3-D collagen gel by Williams, R et al.
63Journal of Cell Science 109, 63-71 (1996)
Printed in Great Britain © The Company of Biologists Limited 1996
JCS8940pS2 transfection of murine adenocarcinoma cell line 410.4 enhances
dispersed growth pattern in a 3-D collagen gel
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*Author for correspondence (e-mail: elalani@rpms.ac.uk)We describe the first model system employing human pS2
gene transfer and expression in a non-pS2-expressing cell
line, mouse mammary adenocarcinoma 410.4, in order to
analyse the potential effect of human trefoil peptide pS2 in
glandular epithelium. Two selected clones, AA4 and AD4,
were established and shown to have incorporated the pS2
cDNA sequence into the genome, express pS2 containing
transcript and produce the pS2 peptide. When grown in 3-
D collagen gels both transfectants show striking morpho-
logical changes compared to the vector control clone (VA5).
VA5 forms large cohesive spherical aggregates with rare
coarse spicular outgrowths, accompanied by prominent
hyalinised extracellular matrix deposition. pS2 transfec-
tants form poorly cohesive, stellate colonies with very little
or no matrix deposition, radiating long cords composed of
single elongated cells, an effect previously observed in other
cell lines with hepatocyte growth factor. pS2 transfection
had no demonstrable effect on proliferation and this is not
a morphogenetic phenomenon, as tubulogenesis is not seen.
Motility assays suggest that the pS2 ‘dispersant’ effect in
collagen gels is due to an increase in cell motility. There
were no measurable alterations in either E-cadherin
expression or E-cadherin-dependent cell-cell aggregation.
pS2 may play a role in maintenance and restitution of
mucosal integrity by accelerating migration/dispersion.
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SUMMARYINTRODUCTION
In 1982 the human pS2 gene was cloned from an expression
library of the oestrogen-dependent human breast adenocarci-
noma cell line MCF-7 (Masiakowski et al., 1982). The
oestrogen-upregulated product of this gene is a 60 amino acid
mature peptide, formed from an 84 amino acid precursor
(Jackowlew et al., 1984; Rio et al., 1988; Mori et al., 1988).
Analysis of the 5¢ flanking region of the pS2 gene revealed a
complex enhancer region responsive to oestrogen, epidermal
growth factor (EGF), tumour promoter 12-tetradecanoyl-
phorbol 13-acetate, c-Ha-ras and c-jun proteins (Nunez et al.,
1989). Several groups have isolated what is now known to be
the same peptide, which has been variously termed BCEI,
pNR-2/-105, Md2 and EGF-immunoreactive factor
(Prud’homme et al., 1990; May and Westley, 1986, 1988; Mori
et al., 1988; Skilton et al., 1989). The homology of pS2 with
porcine pancreatic spasmolytic polypeptide (PSP) and a
protein from the skin of Xenopus laevis led to the proposal of
a new peptide motif, termed the trefoil motif or P-domain
(Thim, 1989; Tomasetto et al., 1990), composed of 38-39
amino acids in which six cysteine residues are disulphide-
linked to form a distinct three-loop structure. From NMR spec-
troscopic and X-ray diffraction studies on PSP (Carr, 1992;
Gajhede et al., 1993) it is clear that trefoil peptides have aunique super-secondary structure distinguishing them from
other highly disulphide cross-linked domains such as EGF
(Gregory and Preston, 1977) and insulin-like growth factor 1
(Blundell and Humbel, 1980; Warne and Laskowski, 1990). To
date three trefoil peptides have been identified in humans.
These are the single-trefoil domain-containing pS2, intestinal
trefoil factor (hITF), and human spasmolytic polypeptide
(hSP), a peptide with a double-trefoil motif (Podolsky et al.,
1993; Hauser et al., 1993; Tomasetto et al., 1990).
pS2, hSP and hITF are highly expressed in regional-specific
patterns throughout the gastrointestinal tract (Rio et al., 1988;
Tomasetto et al., 1990; Podolsky et al., 1993). Thus, although
the pS2 gene was found originally in a human breast cancer
cell line it is expressed constitutively in antrum of the normal
stomach and the peptide is secreted into the gastric juice (Rio
et al., 1988). hSP is widely expressed in gastric foveolar epi-
thelium and gastric glands (Hanby et al., 1993), while hITF is
confined largely to small intestinal and colonic goblet cells
(Podolsky et al., 1993). Mouse spasmolytic polypetide and pS2
as well as rat spasmolytic polypetide and intestinal trefoil
factor have the same distribution as is found in humans
(Lefebvre et al., 1993; Suemori et al., 1991; Tomasetto et al.,
1990). Indeed there is a higher degree of homology among the
same class of trefoils between species than there is between
different trefoils from the same species. Thus there is 67%
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homology between human pS2 and hITF (Lefebvre et al.,
1993; Podolsky et al., 1993). The degree of evolutionary con-
servation in both trefoil structure and distribution clearly
indicates that they have an important function, but their real
physiological role is unclear.
Early studies with purified PSP indicated that it may have
weak physiological effects, including inhibition of intestinal
muscular contraction and gastric acid secretion (Jørgensen et
al., 1982), and a weak proliferative effect on HCT 116 and
MCF-7 cell lines in vitro (Hoosein et al., 1989). A possible
clue to trefoil function emerged with the discovery of increased
expression in a number of physiological and pathological con-
ditions. Of particular interest is the association of pS2 and hSP
expression with mucosal injury and ulceration (Wright et al.,
1990a,b, 1993). Wright et al. (1990b) demonstrated increased
pS2 and hSP expression in the ulcer-associated cell lineage
(UACL) formed in Crohn’s disease. It has been proposed that
trefoil peptides may be involved in the maintenance of mucosal
integrity and may have a role in ulcer healing, tentatively based
on topological evidence. Some evidence for this presumed role
has recently come from the observation that hSP and ITF can
apparently accelerate restitution in an in vitro ‘wounding’
model (Dignass et al., 1994). In addition, it has been shown in
an experimental in vivo model of ulceration in rat stomach that
it is rSP and rITF that are upregulated in response to injury
(Alison et al., 1995). Indeed, the trefoil expression is apparent
before EGF and TGFa peptides, which are more typically
associated with ulcer healing.
pS2 is expressed in adenocarcinomas of the colon, breast,
pancreas, stomach, gall bladder and ovary (Henry et al., 1991;
Seitz et al., 1991), and in cell lines derived from these tissues.
Thus pS2 expression has been demonstrated in human cell
lines of the breast: MCF-7, T47D and ZR75; stomach: Kato3,
MKN45 and MKN28; and pancreas: CAPAN2 and BXPC3
(Mori et al., 1988; Takahashi et al., 1990; our unpublished
observations). In view of this, to examine the effect of pS2 in
isolation, we selected the murine mammary cell line 410.4
because it does not express pS2 (there is no cross-hybridisa-
tion with human pS2 cDNA probe at low stringency). In this
paper we show how the transfection of human pS2 cDNA into
the mouse 410.4 cell line causes changes in growth patterns in
collagen matrix that could be consistent with its putative phys-
iological role.
MATERIALS AND METHODS
Materials
410.4, a murine mammary adenocarcinoma cell line (Dexter et al.,
1978), screened for mycoplasma infection, was obtained from our cell
culture stock. Full-length pS2 cDNA as a BamHI/EcoRI insert in the
pGem1 vector was provided by R. Playford (ICRF, London, UK). All
reagents were purchased from Sigma (Dorset, UK) unless otherwise
stated. The mBCEI1 antibody (Prud’homme et al., 1990) was a gift
from Prof. E. Milgrom (Faculty of Medicine Paris-Sud, Cedex,
France) and the GE1 antibody (Elia et al., 1995) was kindly provided
by G. Elia (ICRF, London, UK).
Cell culture
Unless otherwise indicated, all cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% foetal
bovine serum (FBS) supplied by Gibco BRL Ltd, Paisley, UK.Transfection
Prior to transfection the 410.4 cell line was grown in increasing con-
centrations of puromycin (1-10 m g/ml) to ascertain the level of resis-
tance and death. At a concentration of 2.5 m g/ml no viable cells were
observed after 7 days in culture. The transfection vector pBppS2 was
constructed by insertion of the 490 bp BamHI/EcoRI fragment con-
taining pS2 cDNA into the retroviral expression vector pBabe Puro
(Morgenstern and Land, 1990) (see Fig. 1, below), kindly provided
by H. Land (ICRF, London, UK). Transfection was carried out by a
modification of the CaPO4 method (Chen and Okayama, 1987) using
the Stratagene mammalian transfection kit (Stratagene, Cambridge,
UK). Duplicate 90 mm tissue culture dishes were seeded with 2· 104
410.4 cells per dish and at 20% confluency 10 m g of either pBpps2
(for pS2 transfection) or pBabe Puro (for vector control transfection),
as a CaPO4-DNA precipitate, was added. After 18 hours the medium
was removed and the culture was washed with Dulbecco’s PBSA, pH
7.2, and fresh medium was applied. After a further 24 hours of culture
the cells were split and seeded into 10 Petri dishes at 1000 cells per
dish. Cells were allowed to settle for 24 hours and then subjected to
puromycin selection (2.5 m g/ml). Puromycin-resistant clones were
isolated by ring cloning.
Southern blotting
Genomic DNA was prepared from cells grown to confluency in 15
cm Petri dishes. Cells were washed with ice-cold Dulbecco’s PBSA,
pH 7.2, before addition of 4 ml of lysis buffer (10 mM Tris buffer,
pH 8.0, containing 100 mM NaCl, 10 mM EDTA, 0.5% SDS and pro-
teinase K 50 m g/ml). Lysis was carried out at 37°C for 5 hours. The
cell lysates were then extracted twice with phenol followed by cholo-
roform/isoamyl alcohol (24:1, v/v), and the genomic DNA was
ethanol precipitated. For Southern analysis 20 m g of genomic DNA
was digested with KpnI and then run out on a 0.6% (w/v) agarose gel
in TBE buffer (45 mM Tris base, 45 mM boric acid, 1 mM EDTA,
pH 8, buffer). The DNA was then transferred and fixed to Genescreen
Plus hybridisation Transfer membrane (Du Pont Ltd, Herts, UK) by
the salt transfer protocol (Sambrook et al., 1989).
Northern blotting
Total cellular RNA was isolated by the acid guanidium isothio-
cyanate-phenol-chloroform extraction method (Chomczynski and
Sacchi, 1987) as modified by Cinna/Biotecx (Biogenesis Ltd, Poole,
UK). For northern analysis 20 m g of the RNA samples were denatured
at 65°C for 5 minutes in a solution containing 50% formamide and
2.2 M formaldehyde. The samples were run out on a 0.8% agarose
gel using formaldehyde-containing buffer (20 mM MOPS, 5 mM
NaOAc, 1 mM EDTA, 4.75% formaldehyde). RNA quality and
loading were assessed by ethidium bromide staining. Samples were
transferred to Genescreen Plus hybridisation Transfer membrane in
the presence of 10· SSC (1.5 M NaCl, 0.15 M sodium citrate) and
crosslinked in a UV Stratalinker 2400 (Stratagene, Cambridge, UK).
Hybridisation
Membranes from northern and Southern blots were probed with the
490 bp BamHI/EcoRI insert containing the full-length pS2 cDNA.
The probe was labelled with [a -32P]dCTP (Amersham Life Sciences,
Bucks, UK) by random priming (Sambrook et al., 1989). Hybridisa-
tion was carried out at 42°C overnight in 50% formamide, 10%
dextran sulphate, 1% SDS, 1 M NaCl and 20 m g/ml denatured salmon
sperm DNA. The membranes were washed in 2· SSC for 5 minutes
at room temperature, 2· SSC, 1% SDS for 30 minutes at room tem-
perature, 2· SSC, 1% SDS for 30 minutes at 65°C, 0.2· SSC, 1%
SDS for 30 minutes at 65°C and finally in 0.1· SSC, 1% SDS for 30
minutes at 65°C. The membranes were visualised after exposure to
Hyperfilm-MP film (Amersham Life Sciences, Bucks, UK).
The level of E-cadherin expression was assessed by probing
northern blots of total RNA of cells grown in collagen gel with the
2.5 kb EcoRI fragment of mouse E-cadherin cDNA from the
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Takeichi (Institute of Basic Biology, Kyoto University, Japan).
Immunoprecipitation
Cells for immunoprecipitation (IP) were grown to confluence in 15
cm dishes. Cells were washed in ice-cold Dulbecco’s PBSA, pH 7.2,
and then lysed for 30 minutes on ice with 1 ml of 50 mM Tris-HCl,
pH 7.5, buffer containing 100 mM NaCl, 0.5% Nonidet P40, 0.2 mM
Na3VO4, 50 mM NaF, 2 m g/ml leupeptin, 2 m g/ml aprotinin, 100
m g/ml N-tosyl-L-phenylalanine chloromethyl ketone and 100 m g/ml
4-(2-aminoethyl)-benzenesulphonyl fluoride. Lysates were trans-
ferred to Eppendorf tubes and centrifuged at 13,000 g for 5 minutes.
A 50 m l sample of pre-clearing complex, Protein G-Sepharose
(Pharmacia Biotech Ltd, Herts, UK), incubated with pooled normal
mouse immunoglobulins for 1 hour at 4°C, was added to the super-
natants and incubated for 1 hour at 4°C on a rotator. A 1 m g sample
of GE1 antibody was added to the recovered supernatant. Following
a 1 hour incubation at 4°C, 50 m l of Protein G-Sepharose was added
and a further 1 hour incubation was carried out. The beads were then
washed 5 times with TBST (25 mM Tris-HCl, 150 mM NaCl, pH 7.2,
containing 0.5% Tween 20) and finally resuspended in 50 ml of lysis
buffer (0.5 M Tris-HCl, pH 6.8, buffer containing 10% SDS, 500 mM
EDTA, b -mercaptoethanol and 5% glycerol). The lysates were boiled
for 5 minutes, centrifuged at 13,000 g for 5 minutes and supernatants
run out on a 15% SDS-PAGE gel and electroblotted onto nylon
membranes (Bio-Rad Laboratories Ltd, Herts, UK). The membranes
were washed in TBST, blocked with 5% dried skimmed milk in TBS
(25 mM Tris-HCl, 150 mM NaCl, pH 7.2) for 1 hour at room tem-
perature. The membranes were incubated with mBCEI1 (2.5 m g/ml)
in TBST overnight, then washed in TBST (3· 10 minutes). The
membranes were incubated for 1 hour at room temperature with
biotinylated rabbit anti-mouse IgG antibodies (Dako Ltd, Bucks, UK)
and then developed using the ABC method (Dako Ltd, Bucks, UK)
followed by an ECL chemiluminescence assay (Amersham Life
Sciences, Bucks, UK) and visualised by exposure to Hyperfilm-MP
film (Amersham Life Sciences, Bucks, UK).
Collagen gels
Quadruplicate collagen type 1 gels using Vitrogen 100 (Celtrix Phar-
maceuticals, Santa Clara, CA) and bovine dermal collagen were made
up according to the manufacturer’s instructions. Briefly, 8 vol. of
collagen stock solution was mixed with 1 vol. of 10· DMEM, neu-
tralised with 0.1 M NaOH and made up to 10 vol. with sterile distilled
water in a sterile flask on ice. A 0.5 ml sample of appropriate cells
was added to 5 vol. of the gel solution to give a final concentration
1· 104 cells per ml, and 1 ml aliquots were dispensed into 35 mm
tissue culture dishes and allowed to gel for about 15 minutes at 37°C
before addition of culture medium. For surface collagen gel growth
studies gels were set up as above except that the cells (1· 104 cells per
gel) were added after the collagen gels had set. All collagen gels were
fed with DMEM/10% FBS containing 2.5 mg/ml puromycin every 72
hours. Growth was assessed every 24 hours by examination under an
Olympus IMT-2 phase-contrast microscope and followed for a
maximum of 21 days. Collagen gels were fixed at weekly intervals in
10% formol saline overnight, processed and subsequently paraffin-
embedded and serially sectioned (5 m m sections).
Histology and immunocytochemistry
Sections were routinely stained with haematoxylin and eosin (H and
E). For fibronectin, type IV collagen and laminin detection sections
were digested with protease for 20 minutes at 37°C and then stained
immunohistochemically using a diaminobenzidine peroxidase-
antiperoxidase technique using a 1 in 100 dilution of either anti-
human laminin rabbit polyclonal antibody (EURO-PATH, Bude, UK)
or anti-human fibronectin rabbit polyclonal antibody (Dako Ltd,
Bucks, UK). The anti-human collagen type IV rabbit polyclonal
antibody (EURO-PATH, Bude, UK) was used at a 1 in 1000 dilutionand developed using the ABC method. All of the antibodies cross-
react with mouse proteins.
Quantification of colony type
A total of 300 colonies for each clone were counted from H and E-
stained en face sections of collagen gels after 14 days growth (two
separate sets of four collagen gels). The colonies were assigned to one
of three categories: circumscribed, branched or dispersed (for a
description see Results).
Cell aggregation assay
For the aggregation assay cells were grown in T75 cm3 flasks to 70-
80% confluency. The cells were washed with PBSA prewarmed to
37°C and then incubated with 5 ml of a non-enzymic cell-dissocia-
tion medium (Sigma, Dorset, UK) for 10 minutes at 37°C. Cells were
washed with Ca2+- and Mg2+-free DMEM to obtain a single cell sus-
pension. A total of 3 · 106 cells were suspended in 3 ml of DMEM
containing 0.8% FBS and incubated in a gyration shaker rotating at
100 rpm at 37°C. Duplicate 10 m l samples were withdrawn after 0,
15, 30, 45 and 60 minutes of incubation and the number of single cells
was counted. The assay was repeated a total of 5 times and the data
presented as (Nt/No)· 100, where Nt and No refer to the number of
single cells at time t and 0, respectively.
Motility assay using time-lapse videomicroscopy
Time-lapse videomicroscopy experiments were performed using
Olympus IMT 1 or 2 microscopes that were enclosed within environ-
mental chambers. High resolution monochrome CCD cameras (Sony
M370CE) were attached to each microscope. Images were recorded
using broadcast quality videorecorders (Sony Betacam PVW 2800)
that were driven externally by animation controllers (BAC 900 from
EOS Electronics AV Ltd, Barry, S. Wales). 
For the motility assay cells were plated on 35 mm dishes at 104
cells per dish, 24 hours before the start of the assay. A field contain-
ing between 30 and 40 cells was chosen for each cell line. Images
were recorded at one frame every minute for 24 hours. The record-
ings were downloaded onto an S-VHS videorecorder (Mitsubishi B-
82), which was linked to an Apple MacIntosh 6100 computer, and the
cells that remained within the observed field for the duration of the
film were tracked using Cell Motility software (EOS Electronics). A
printout of the track of each cell was obtained together with calcula-
tion off the mean distance and speed for each cell line.
RESULTS
Characterisation of transfected clones
For transfection the pS2 cDNA, a 490 bp BamHI/EcoRI
restriction fragment, was inserted into the pBabe Puro retrovi-
ral expression vector as is shown in Fig. 1. In this vector the
promoter in the 5¢ Mo MuLV long terminal repeat (LTR) is
used to transcribe the pS2 inserted gene and the internal SV40
early promoter expresses puromycin drug resistance marker,
both transcripts sharing a common termination and poly-
adenylation signal in the 3¢ LTR. Transfectants were selected
by their ability to grow in media supplemented with puromycin
at 2.5 m g/ml, a concentration that was shown to kill 410.4 cells.
Two pS2 cDNA transfected clones (AA4, AD4) and one clone
(VA5) from transfection with pBabe Puro were isolated by ring
cloning. Genomic DNA isolated from all three clones (AA4,
AD4 and VA5) and the parental cell line was digested with
KpnI, Southern blotted and hybridised with a pS2 cDNA probe.
The resulting blot (Fig. 2A) shows that both AA4 and AD4
display a single band of 3 kb; by contrast, neither the parental
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Fig. 2. Characterisation of transfectants. (A) Southern blot of
genomic DNA from transfectants and parental cell line. A 20 m g
sample of genomic DNA was digested with KpnI and run out on a
0.6% agarose gel in TBE. The DNA was transferred to a GeneScreen
nylon membrane and probed with 32P-labelled 490 bp pS2 cDNA.
(B) Northern blot of total RNA from transfectants and parental cell
lines. A 20 m g sample of total RNA was run out on 0.8% agarose
formaldehyde gel and transferred to a GeneScreen nylon membrane.
The membrane was probed with 32P-labelled 490 bp pS2 cDNA.
(C) Immunoprecipitation of pS2 peptide from transfected clones.
GE1 immunoprecipitates from cell lysates were run out on a 15%
SDS-PAGE gel and transferred to nitrocellulose membrane. The
membrane was developed with the anti-pS2 antibody mBCEI1.
Throughout, lane 1 refers to AA4 clone, lane 2 to AD4 clone, lane 3
to the vector control (VA5) and lane 4 to the parental cell line.
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Fig. 1. Map of pBppS2
transfection vector.cell line nor the vector control VA5 clone shows any bands.
The 3 kb band is in keeping with the expected size of the KpnI
fragment of the pBppS2, since there is one KpnI site in each
of the LTRs (see Fig. 1), and indicates no gross rearrangement
or truncation of integrated DNA copy. This clearly demon-
strates that both pS2 transfected clones have incorporated the
pS2 cDNA into the 410.4 genome.
The presence of pS2 transcripts in the clones was determined
by northern analysis of total RNA. The northern blot analysis
for pS2 containing transcripts (Fig. 2B) shows clear 3.5 kb
bands in both the AA4 and AD4 clones that correspond to the
expected full-length transcript from 5¢ viral LTR (see Fig. 1).
The presence of an extra band at 2 kb in the AD4 clone tract
may be due to a splicing event from the cryptic termination or
a poly(A) site at the 3 ¢ end of the pS2 cDNA insert (Dai et al.,
1993; Kirschmeier et al., 1988). This band is also observed in
the AA4 clone on prolonged exposure of the northern blot (data
not shown). Levels 6-fold higher, as determined by laser den-
sitometry (Molecular Dynamics, Bucks, UK), of the transcript
are present in the AD4 clone. No bands were evident with VA5
or 410.4 RNA samples.
To ascertain whether the transcripts were appropriately
translated immunoprecipitation was carried out on the cell
lysates using the GE1 anti-pS2 antibody. Fig. 2C shows a
western blot of the immunoprecipitates developed using the
anti-pS2 mBCEI1 antibody. Bands at approximately 7 kDa
were shown by AD4 and AA4 but not 410.4 and VA5. The
band size matches that obtained for pS2 immunoprecipitation
from MCF-7 cells (Elia et al., 1995). It is also evident that the
AD4 clone expresses greater amounts of pS2 peptide than the
AA4 clone. From these results we can say that both AD4 and
AA4 contain pS2 cDNA at the genomic level, produce pS2-
containing transcripts and produce the correct translation
product.
Growth on plastic and in type 1 collagen gels
When grown on plastic the pS2 transfected clones AD4 and
AA4 showed the same morphology as the vector control trans-
fectant (VA5) and the parental cell line. No difference in cyto-
logical characteristics or growth rate measured by DNA flu-
orimetry (Rao and Otto, 1992) was evident (data not shown). 
Phase contrast microscopy (7-14 days)
To establish whether expression of pS2 would lead to differ-ences in growth pattern the clones were propagated in type 1
collagen matrix. Phase-contrast microscopy showed marked
differences in the growth pattern of the transfectants as early
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Fig. 3. Growth of transfectants in
collagen type 1 gels. (A) A phase-
contrast photograph of VA5
colonies formed after 14 days
growth in collagen gel. (B) H and
E-stained en face section of a
typical VA5 colony. (C) A phase-
contrast photograph of a typical
AD4 colony after 14 days growth
in collagen gel. (D) H and E-
stained en face section of a typical
AD4 colony. (E) A phase-contrast
photograph of AA4 colonies
formed after 14 days growth in
collagen gel. (F) H and E-stained
en face section of typical AA4
colony. Bars, 150 m m.as after 7 days of growth. Both the parental and vector control
(VA5) cell lines formed small tight compact spherical colonies
(Fig. 3A), while the pS2 transfectants formed dispersed stellate
structures with peripheral thin extensions (Fig. 3C,E). These
differences became even more pronounced after 14 days in
culture.
Histology of cells grown in collagen (7-14 days)
H and E-stained sections of the collagen gels (Fig. 3B) show
that VA5 forms tight compact colonies with circumscribed
margins, composed of large cells with abundant cytoplasm. In
addition there is prominent extracellular matrix deposition in
the colony shown up as hyaline eosinophilic aggregates. Occa-
sional less circumscribed colonies with broad short projections
into the gel were observed. The parental cell line had a similar
appearance. Sections of the transfectants show that the
dispersed structures with radiating cords are essentially
composed of extensive cords of elongated single cells
migrating out into the gel (Fig. 3D,F). No tubular formationswere observed and thus this process is not regarded as a mor-
phogenetic phenomenon. No matrix deposition was evident.
Confirmation that pS2 was expressed in cells grown in collagen
was obtained from northern analysis of pS2 RNA extracted
from cells grown in collagen gel. A similar level of pS2-con-
taining transcript was produced as was observed with cells
grown on plastic (data not shown).
Quantitative analysis of structures
Three types of colonies were quantified on the gel sections.
Circumscribed colonies were typified by VA5. Branching
colonies had outgrowths into the gel, which are short, often
clubbed and composed of rounded or polygonal cells, which
are often over 2 cells in width. Dispersed colonies had radiating
cords of cells, usually elongated, with no more than 1-2 cells
at the extremities. Fig. 4 shows a quantitative analysis of the
colony type formed by the transfectants (day 14). The vector
control VA5 showed predominantly circumscribed structures
(94.5%) with some branching (4.2%), and very little in the way
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Fig. 4. Quantification of colony types formed by transfectants in
collagen gels. The type of colonies formed by the pS2 transfectants
AD4 and AA4 and the vector control VA5 were counted in H and E-
stained en face sections from two separate sets of four collagen gels
after 14 days growth (300 colonies were counted). The results
represent the mean ± s.e.m.
Table 1. Motility assay
Cell line Cell motility (m m/h)
VA5 12.64±1.13
AD4 29.87±1.75
The results represent the mean speed (m m/h) determined for 40 cells of
each cell line ± s.e.m.of dispersed colonies (1.3%) was evident. Some of these may
even have arisen by intracolony cell death and regeneration, as
they appeared to contain cellular debris. Only 3% of AD4 and
5% of AA4 colonies were circumscribed, with a majority being
dispersed, 80% in the case of AD4 and 68% for AA4. There
would appear to be a correlation between the extent of disper-
sion and the level of pS2 expression. The higher pS2 express-
ing clone AD4 showed a greater tendency to form dispersed
colonies than the lower expressor AA4.
Growth on type 1 collagen gels
When the clones were grown on the surface of collagen gels a
similar difference was observed in the growth pattern of the
pS2 transfectants compared to the vector control. Under phase-
contrast the parental and VA5 cell lines (vector control) formed
large circumscribed spherical colonies showing very little
lateral migration, whereas the transfectants spread over the gel
surface. Each gel was longitudinally serially sectioned and
stained. Sections of the parental gel showed large spherical
colonies protruding above the surface of the gel, with very
prominent deposits of ECM forming hyaline eosinophilic
aggregates (Fig. 5A). The pS2 transfected clones spread out
over the surface of the gel with no nodular growths or ECM
deposition (Fig. 5B,C). Significantly, we found no evidence of
invasion into the collagen gel by VA5, AD4 or AA4 clones.
Immunocytochemistry (data not shown) on sections did not
reveal any significant difference in the amount of laminin,
fibronectin and collagen type IV staining between the pS2
transfected clones and the vector control, although these com-
ponents tended to be more spread out in close approximation
to the cells in the transfectants. However, the majority of the
eosinophilic ECM did not show specific immunoreactity for
specific matrix components, which is predictable from studies
on hyalinised ECM in human tissues.
It has been reported that dispersant growth patterns of cells
are mediated by changes in their cadherin-based cell adhesion
ability (Behrens et al., 1993) and that E-cadherin expression isfrequently down-regulated in highly invasive, poorly differen-
tiated carcinomas (Frixen et al., 1991; Behrens et al., 1991;
Pignatelli et al., 1992). The level of E-cadherin expression of
the transfectants was assessed by northern analysis of total
RNA extracted from cells grown in collagen gel using a mouse
E-cadherin cDNA probe (Nose et al., 1988). A single band of
4.5 kb was observed in all RNA samples and there was no dif-
ference in the level of expression in the pS2 transfectants
compared to the VA5 and parental cell lines as determined by
densitometric analysis (data not shown). To determine whether
the observed changes were due to changes in E-cadherin-
mediated cell adhesion, the calcium-dependent cell-cell aggre-
gation of the pS2 transfectants was compared with that of the
vector control. From Fig. 6 it is evident that pS2 expression
does not result in any changes in the calcium-dependent cell-
cell aggregation. It is therefore unlikely that the observed dis-
persant growth pattern of the pS2 transfectants changes are due
to alteration in E-cadherin function.
It is possible that the changes in growth pattern of 410.4 cells
as a result of pS2 expression could be explained by pS2 causing
an increase in cell motility. To test this a motility assay was
carried out on AD4 pS2 transfectant and the vector control
VA5. The results show that the pS2 transfectant has a 2.4-fold
increase in motility over that of the vector control cell line
(Table 1).
DISCUSSION
We describe the first model system employing human pS2 gene
transfer and expression in a non-pS2-expressing cell line.
There is a high degree of conservation between human and
mouse pS2 (Lefebvre et al., 1993), and we could not show any
cross-hybridisation of human pS2 probes in the parental cell
line at low stringency. Our findings were that both the AD4
and AA4 clones had integrated the pS2 cDNA into the 410.4
genome, and produced pS2-containing transcripts and the
mature pS2 peptide. The AA4 transfectant showed lower levels
of pS2 transcript and peptide compared to the AD4 clone.
From the growth in collagen type 1 gels it is clear that pS2
expression in the two transfectants resulted in a more dispersed
pattern of growth. The vector control clone (VA5), like the
parental cell line, typically formed cohesive islands of cells
showing no invasion into the collagen matrix, with prominent
ECM deposition. The pS2 transfectants tended to form poorly
cohesive stellate colonies from which radiate thin cords of
elongated cells into the collagen matrix, with no visible ECM
deposition. The extent to which the transfectants formed these
dispersed structures appeared to correlate with the level of pS2
expression, with the lower pS2 expressor, AA4, showing a
smaller degree of dispersion.
Assay of cellular motility using videomicroscopy clearly
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by the AD4 transfectant. Since dispersion might be a conse-
quence of reduced intercellular cohesion, which is primarily
mediated by E cadherin (Takeichi, 1991), we performed cell-
cell aggregation assays, which showed no differences between
vector controls and transfectants. Moreover, there were no dif-
ferences in E cadherin expression as determined by northern
analysis.
Thus pS2 appears to exert a motogenic effect on 410.4 cells,
but not a mitogenic or a morphogenetic effect. A similar
motogenic or ‘scatter’ effect is induced by hepatocyte growth
factor (HGF), which has been shown to dissociate layers of
epithelial cells, increasing their motility and invasiveness
(Stoker et al., 1987; Weidner et al., 1990). However, HGF is
also a mitogen for kidney tubular epithelium, keratinocytes,
endothelial cells and melanocytes (Rubin et al., 1991;
Bussolino et al., 1992), and can function as a morphogen stim-
ulating the three-dimensional organisation of Madin-Darby
canine kidney cells (MDCK) (Montesano et al., 1991). It has
also been shown to promote the progression of carcinoma cells
towards a malignant invasive phenotypes (Weidner et al.,
1990). 
Early studies with PSP suggested that this trefoil had a
mitogenic activity towards MCF-7 and HCT 116 cell lines
(Hoosein et al., 1989). However, the levels of PSP required to
elicit a response were 10 times higher than the expected range
for most growth factors. We have been unable to reproduce
this effect and have found no mitogenic activity for hSP in a
number of cell lines (unpublished observations). Recently,
Dignass et al. (1994) also failed to observe any mitogenic
activity for hSP, rITF and hITF on a panel of cell lines. In this
study, expression of pS2 had no effect on the proliferation of
the 410.4 cell line. It therefore seems unlikely that trefoils are
mitogens. Since we did not demonstrate any invasive action of
pS2-expressing cells from the surface into the collagen matrix,
it may be that pS2, unlike HGF, induces a spreading rather than
an invasive phenotype. Indeed, we have demonstrated that pS2
expression results in increased cell motility.
The changes in growth pattern of the 410.4 cell line brought
about by pS2 expression were associated with an alteration in
ECM deposition. Prominent deposits of ECM were shown by
the vector control. Both the pS2 transfectants showed very little
in the way of visible ECM when propagated in or on the surface
of collagen gels. No quantitative differences in type IV
collagen, fibronectin or laminin were apparent apart from redis-
tribution commensurate with the alteration in growth pattern. It
may be that other components of the ECM associated with cell
migration and spreading, such as tenascin, vitronectin or
laminin fragments, possibly in the non-immunoreactive parts of
the ECM, could be responsible for these effects.
It has been demonstrated that the motogenic and mor-
phogenic activity in epithelial cells induced by HGF is associ-
ated with degradation of ECM. Thus the HGF-induced mor-
phogenesis of MDCK cells when grown in collagen type 1 is
repressed by protease inhibitors (Montesano et al., 1991). It is
conceivable that pS2 expression leads to an increased
expression of proteases, resulting in a degradation in ECM,
which leads to a loosening of cell interaction, an area that we
are currently investigating.
Is there any relationship between these in vitro effects of pS2
and its physiological role? Trefoil peptides are a normalcomponent of the gastrointestinal mucosa. The expression of
trefoil peptides in response to mucosal injury has led to the
suggestion that they participate in the ulcer-healing response.
Thus pS2 and hSP expression is found in the ulcer-associated
cell lineage (UACL) in chronic ulcerative conditions such as
Crohn’s disease (Wright et al., 1990a,b, 1993). This differen-
tiating cell lineage buds from the bases of intestinal crypts
adjacent to the ulcer, ramifying and anastomosing in the
submucosa and finally fusing with the villous epithelial surface
via terminal ducts (Wright et al., 1990a). UACL development
with concomitant pS2/hSP expression has also been observed
at other sites of chronic endodermal injuries such as ducts in
chronic pancreatitis or biliary obstruction, and in nasal polyps
(Wright et al., 1990b; Seitz et al., 1991).
Healing of ulcerative lesions occurs throughout the gastroin-
testinal tract and is characterised by the ability to reconstitute
the mucosa followed by the re-formation of specialised struc-
tures. When a mucosal defect occurs, it is initially covered by
a layer of necrotic cells, fibrin and mucus termed the ‘mucoid
cap’. This mucoid cap may be of particular importance in the
stomach in re-establishing a pH gradient so that the cells of the
surviving mucosa are maintained at a neutral pH rather than that
of the acidic gastric juice (Wallace and Whittle, 1986). Epi-
thelial cells at the margin of the defect migrate to re-establish
a continuous epithelial layer. This process is termed ‘epithelial
restitution’. Restitution occurs within the first hour following
injury and over the next 48 hours cellular proliferation and
differentiation in adjacent glands occur, re-establishing the
normal architecture. In ulcer healing it is the re-epithelialisation
of the damaged area that is the important first response and this
is achieved by epithelial cells from the wound edges migrating
into the area, and does not involve a proliferative response (at
least initially). Indeed it has been shown that healing of mucosal
erosions (injury not involving the full thickness of the mucosa)
in rats is very rapid. Silen and Ito (1985) have demonstrated
complete re-epithelialisation of totally desquamated surfaces
within 1 hour by migration of cells from neighbouring pits
before cell proliferation and inflammation.
Our observation that pS2 has the potential to induce a
migratory response, taken together with the topographical
expression of pS2 in response to ulcerative damage, supports
a role for trefoil peptides in ulcer healing. Our results are com-
patible with the recent observation that showed that two trefoil
peptides, intestinal trefoil factor (ITF) and human spasmolytic
polypetide (hSP), accelerated restitution of wounded mono-
layers in an in vitro restitution assay (Dignass et al., 1994).
This study also demonstrated that the effect is not necessarily
species-specific, since hITF was as effective as its rat equiv-
alent in the restitution assays carried out on rat intestinal epi-
thelial cell lines. Further support for the proposed role comes
from the observation of an up-regulation of rSP and rITF at
ulcer margins in experimentally induced gastric ulcers in rat
(Alison et al., 1995). This expression of the trefoils in
response to injury occurs prior to the expression of the EGF
and TGF a molecules traditionally associated with ulcer
healing. It is conceivable that pS2, as well as other trefoils,
initiates the healing process by induction of a migratory
response in the epithelial population around the margins of the
ulcer. This would explain the high levels of pS2 and hSP
expression in the gastric mucosa, since a high level of resti-
tutive peptides would be necessary to enable a rapid re-estab-
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Fig. 5. Growth on collagen type 1 gels. (A) H and E-stained section
of parental cells grown on collagen gel. (B) H and E-stained section
of AD4 clone grown on collagen gel. (C) H and E-stained section of
AA4 clone grown on collagen gel. (In all figures the collagen gels
were embedded on edge after 14 days in culture and the sections are
oriented with the collagen gel at the bottom of the field.)
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Fig. 6. Cell aggregation assay. Nt and N0 refer to the number of
single cells at time t and time 0, respectively. The results represent
the mean values of five separate experiments ± s.e.m.lishment of mucosal integrity in a particularly hostile envi-
ronment. Presumably, the formation of UACL at sites of more
extensive damage provides a large pool of trefoils to facilitate
restitution.
Our data are therefore consistent with a role for trefoil
peptides in the maintenance and restoration of mucosal
integrity following mucosal injury and ulceration.The authors thank Jonathan Wilding for his contribution to this
work. This work is supported by the Wellcome Trust and the Crohn’s
in Childhood Research Association.
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